31. Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus. (August 2019) Authors: Pappa, E.; Arvaniti, E.; Dimou, A.; Kostara, C.; Tellis, K.; Tselepis, A.; Bairaktari, E.; Elisaf, M.; Tsimihodimos, V. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus. (August 2019) Authors: Pappa, E.; Arvaniti, E.; Dimou, A.; Kostara, C.; Tellis, C.; Tselepis, A.D.; Bairaktari, E.; Elisaf, M.; Tsimihodimos, V. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Effects of evolving lipid-lowering drugs on carbohydrate metabolism. (March 2018) Authors: Tsimihodimos, V.; Elisaf, M. Journal: Diabetes research and clinical practice Issue: Volume 137(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Fractional excretion of potassium in normal subjects and in patients with hypokalaemia. Issue 834 (April 1995) Authors: Elisaf, M.; Siamopoulos, K. C. Journal: Postgraduate medical journal Issue: Volume 71:Issue 834(1995) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Glucagon-like peptide 1 receptor agonists and protection against stroke: a systematic review and meta-analysis. (August 2018) Authors: Milionis, H.; Barkas, F.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Glucagon-Like Peptide 1 Receptor Agonists Protect Against Stroke In Patients With Diabetes: A Systematic Review And Meta-Analysis. (August 2019) Authors: Barkas, F.; Elisaf, M.; Filippas-Ntekouan, S.; Klouras, E.; Milionis, H. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Hypertriglyceridemia, remnant cholesterol and cardiovascular risk: what genes can say. Issue 2 (28th January 2016) Authors: Kei, A.; Elisaf, M. Journal: International journal of clinical practice Issue: Volume 70:Issue 2(2016) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Hypertriglyceridemia, remnant cholesterol and cardiovascular risk: what genes can say. Issue 2 (February 2016) Authors: Kei, A.; Elisaf, M. Journal: International journal of clinical practice Issue: Volume 70:Issue 2(2016) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Incidence of cardiovascular disease among individuals with and without familial hypercholesterolemia attending a lipid clinic. (September 2016) Authors: Barkas, F.; Klouras, E.; Dimitriou, T.; Liamis, G.; Elisaf, M.; Liberopoulos, E. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Incidence of cardiovascular disease in patients with dyslipidemia receiving multifactorial cardiovascular prevention therapy. (August 2021) Authors: Barkas, F.; Anastasiou, G.; Adamidis, P.; Elisaf, M.; Koutsogianni, A.-D.; Liberopoulos, E.N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗